Tapsall J W
Department of Microbiology, Prince of Wales Hospital, Randwick, Sydney, New South Wales, Australia.
Commun Dis Intell. 2000 Jan 20;24(1):1-4. doi: 10.33321/cdi.2000.24.1.
Effective treatment of gonorrhoea in the World Health Organization's Western Pacific Region is hampered by the emergence and spread of antibiotic resistant strains of Neisseria gonorrhoeae. A programme of surveillance of gonococcal susceptibility to antibiotics (GASP) continued in the region in 1998. A high proportion of isolates in many participating countries was resistant to quinolones and penicillins, continuing trends observed by this programme since 1992. Resistance to the later generation cephalosporins and to spectinomycin was absent or infrequent. Options for effective treatment of gonorrhoea in the region have been severely compromised by antibiotic resistance.
淋病奈瑟菌抗生素耐药菌株的出现和传播阻碍了世界卫生组织西太平洋区域对淋病的有效治疗。1998年,该区域继续开展了淋病奈瑟菌对抗生素敏感性监测项目(GASP)。自1992年该项目开展以来,许多参与国的大部分分离株对喹诺酮类和青霉素类耐药,这一趋势仍在持续。对新一代头孢菌素类和大观霉素耐药的情况不存在或很少见。抗生素耐药性严重影响了该区域有效治疗淋病的选择。